nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allogeneic Hematopoietic Cell Transplantation in Septuagenarians
|
Grunwald, Michael R. |
|
2013 |
19 |
9 |
p. 1276-1278 3 p. |
artikel |
2 |
A Novel Soluble Form of Tim-3 Associated with Severe Graft-versus-Host Disease
|
Hansen, John A. |
|
2013 |
19 |
9 |
p. 1323-1330 8 p. |
artikel |
3 |
Challenges and Opportunities for International Cooperative Studies in Pediatric Hematopoeitic Cell Transplantation: Priorities of the Westhafen Intercontinental Group
|
Schultz, Kirk R. |
|
2013 |
19 |
9 |
p. 1279-1287 9 p. |
artikel |
4 |
Cord Blood–Derived and Peripheral Blood–Derived Cytokine-Induced Killer Cells Are Sensitive to Fas-Mediated Apoptosis
|
Durrieu, Ludovic |
|
2013 |
19 |
9 |
p. 1407-1411 5 p. |
artikel |
5 |
Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
|
Cornell, Robert Frank |
|
2013 |
19 |
9 |
p. 1368-1373 6 p. |
artikel |
6 |
Editorial Board
|
|
|
2013 |
19 |
9 |
p. A4- 1 p. |
artikel |
7 |
Enrichment of IL-12–Producing Plasmacytoid Dendritic Cells in Donor Bone Marrow Grafts Enhances Graft-versus-Leukemia Activity in Allogeneic Hematopoietic Stem Cell Transplantation
|
Darlak, Katarzyna A. |
|
2013 |
19 |
9 |
p. 1331-1339 9 p. |
artikel |
8 |
Establishing a Target Exposure for Once-Daily Intravenous Busulfan Given with Fludarabine and Thymoglobulin before Allogeneic Transplantation
|
Russell, James A. |
|
2013 |
19 |
9 |
p. 1381-1386 6 p. |
artikel |
9 |
Exposure of Early Pediatric Trainees to Blood and Marrow Transplantation Leads to Higher Recruitment to the Field
|
Shereck, Evan |
|
2013 |
19 |
9 |
p. 1399-1402 4 p. |
artikel |
10 |
Fludarabine and 2-Gy TBI is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial
|
Kornblit, Brian |
|
2013 |
19 |
9 |
p. 1340-1347 8 p. |
artikel |
11 |
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation
|
Sanz, Jaime |
|
2013 |
19 |
9 |
p. 1387-1392 6 p. |
artikel |
12 |
Intermittent Zoledronic Acid Prevents Bone Loss in Adults after Allogeneic Hematopoietic Cell Transplantation
|
Hari, Parameswaran |
|
2013 |
19 |
9 |
p. 1361-1367 7 p. |
artikel |
13 |
Low Levels of Interleukin-1 Receptor Antagonist (IL-1RA) Predict Engraftment Syndrome after Autologous Stem Cell Transplantation in POEMS Syndrome and Other Plasma Cell Neoplasms
|
Keyzner, Alla |
|
2013 |
19 |
9 |
p. 1395-1398 4 p. |
artikel |
14 |
Lung Function after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Longitudinal Study in a Population-Based Cohort
|
Uhlving, Hilde Hylland |
|
2013 |
19 |
9 |
p. 1348-1354 7 p. |
artikel |
15 |
Masthead (Purpose and Scope)
|
|
|
2013 |
19 |
9 |
p. A2- 1 p. |
artikel |
16 |
Mice Engrafted with Human Fetal Thymic Tissue and Hematopoietic Stem Cells Develop Pathology Resembling Chronic Graft-versus-Host Disease
|
Lockridge, Jennifer L. |
|
2013 |
19 |
9 |
p. 1310-1322 13 p. |
artikel |
17 |
Monoclonal Antibodies in Conditioning Regimens for Hematopoietic Cell Transplantation
|
Kharfan-Dabaja, Mohamed A. |
|
2013 |
19 |
9 |
p. 1288-1300 13 p. |
artikel |
18 |
Officers and Directors of ASBMT
|
|
|
2013 |
19 |
9 |
p. A5- 1 p. |
artikel |
19 |
Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
|
Brunner, Andrew M. |
|
2013 |
19 |
9 |
p. 1374-1380 7 p. |
artikel |
20 |
Pharmacoeconomics of Hematopoietic Stem Cell Mobilization: An Overview of Current Evidence and Gaps in the Literature
|
Shaughnessy, Paul |
|
2013 |
19 |
9 |
p. 1301-1309 9 p. |
artikel |
21 |
Similar Overall Survival Using Sibling, Unrelated Donor, and Cord Blood Grafts after Reduced-Intensity Conditioning for Older Patients with Acute Myelogenous Leukemia
|
Peffault de Latour, Régis |
|
2013 |
19 |
9 |
p. 1355-1360 6 p. |
artikel |
22 |
Specific Features Identify Patients with Relapsed or Refractory Mantle Cell Lymphoma Benefitting from Autologous Hematopoietic Cell Transplantation
|
Cassaday, Ryan D. |
|
2013 |
19 |
9 |
p. 1403-1406 4 p. |
artikel |
23 |
Table of Contents
|
|
|
2013 |
19 |
9 |
p. A6-A8 nvt p. |
artikel |
24 |
Temporal Changes in Plerixafor Administration and Hematopoietic Stem Cell Mobilization Efficacy: Results of a Prospective Clinical Trial in Multiple Myeloma
|
Harvey, R. Donald |
|
2013 |
19 |
9 |
p. 1393-1395 3 p. |
artikel |
25 |
The Quest for the Optimal Conditioning Regimen: Some Answers, More Questions
|
Mapara, Markus Y. |
|
2013 |
19 |
9 |
p. 1275-1276 2 p. |
artikel |